There was only one really bad performer and that was TLOU:Tlou Energy which dropped 5% for the second week in a row to go 39% down. I'm still confident things are moving in the right direction here, but it's high risk so won't be buying any more.
The trading account had some good cheer when TRMR:Tremor climbed 6% this week. It's still 53% down so there's a long way to go before I'm prepared to sell.
Share of the Week was IQE:IQE, which climbed 12% of purchase price in the SIPP where it is 49% down, 14% in the trading account where it is 38% down and a whopping 20% in the ISA where it is only 11% down. The ISA was meant to be a short-term buy, so if it can just climb back to 75p I can flog them and put them where I want them to be in SBTX:SkinBioTherapeutics and CWR:Ceres Power.
At least it didn't get worse.
Wrong side of the steepening trend line, but in 3 weeks the mountain disappears.
The ISA and share accounts look like this
Weekly Change | |||
Cash | £27.36 | +£0 | |
Portfolio cost | £57,887.63 | +£0 | |
Portfolio sell value (bid price-commission) | £48,620.39 | (-16%) | +£8.68 |
Potential profits | £2,233.44 | -£208.15 | |
Yr 4 Dividends | £103.97 | +£0 | |
Yr 4 Profit from sales | £1,659.19 | +£0 | |
Yr 4 Average monthly cash profit | £146.31 | (3.0%) | -£2.92 |
Total Dividends | £1,342.30 | +£0 | |
Total Profit from sales | £20,356.31 | +£0 | |
Average monthly cash profit | £450.31 | (9.3%) | -£2.18 |
(Sold stocks profit + Dividends - Fees / Months) |
OPTI:Optibiotix dropped 0.4p which took £208 off the profits, but reduced losses mainly in IQE:IQE meant the account stayed just about in the black this week. Next week is the last week of Year 4, so it's looking like a really poor one for returns, with an average of just 3% per month. I doubt there will be an opportunity to sell anything next week, unless IQE:IQE goes bonkers.
Very similar to the overall chart, and the mountain will also leave here in 3 weeks to help flatten the trend line.
The SIPP looks like this after week 191
Weekly Change | |||
Cash | £131.10 | +£50.01 | |
Portfolio cost | £41,232.99 | +£0 | |
Portfolio sell value (bid price - commission) | £38,412.67 | (-6.8%) | -£128.71 |
Potential profits | £1,562.49 | -£270.26 | |
Yr 4 Dividends | £361.99 | +£0 | |
Yr 4 Interest | £0.09 | +£0.01 | |
Yr 4 Profit from sales | £743.60 | +£0 | |
Yr 4 Average monthly cash profit | £123.58 | (3.6%) | -£3.64 |
Total Dividends | £1,704.24 | +£0 | |
Total Interest | £0.12 | +£0.01 | |
Total Profit from sales | £11,288.52 | +£0 | |
Average monthly cash profit | £285.94 | (8.3%) | -£1.50 |
(Sold stocks profit + Dividends - Fees / Months) |
Much worse than the ISA, with the reduced losses not being enough to cancel the OPTI:Optibiotix drop, and CAML:Central Asia Metals dropped as well. I need to sell something! £50 arrived as a tax rebate and I got 1p interest on the account.
I've had confirmation that my transfer request is being processed so the £2,200 may come through next week. I keep saying I should keep it as cash, but SBTX:SkinBiotherapeutics is now below my purchase price so I at least want to get back to the number of shares before I last sold. OPTI:Optibiotix is madly cheap, and CAML:Central Asia Metals is also deserving of a top-up, so the cash won't be lying around for long. I think £550 of SBTX to get me past 10,000 shares. £850 would make CAML 10% of my portfolio cost, and that would leave £800 for an OPTI top-up. Unfortunately CWR:Ceres Power have spiked up recently and are likely to drift down, so the timing isn't right to buy back there.
If any of them head upwards before the money arrives I'll have to re-think.
The trading account looks like this
Weekly Change | |||
Cash | £35.04 | +£0 | |
Portfolio cost | £2,321.29 | +£0 | |
Portfolio sell value (bid price - commission) | £1,397.30 | (-39.8%) | +£89.48 |
Potential profits | £0 | +£0 | |
Year 4 Dividends | £0 | +£0 | |
Year 4 Profit | £0 | +£0 | |
Yr 4 Average monthly cash profit | £0 | (0%) | +£0 |
Dividends | £34.72 | +£0 | |
Profit from sales | -£64.29 | +£0 | |
Average monthly cash profit | -£0.82 | (-0.4%) | +£0 |
(Sold stocks profit + Dividends - Fees / Months) |
A great week for IQE:IQE and TRMR:Tremor, offset slightly by a bad week for CAML:Central Asia Metals. There was hopeful news from LION:Lionsgold as I received a message from my broker that they have changed to TALY:Tally Ltd. I'm suspecting they would only do that if they were planning to re-list fairly soon, so fingers crossed!
Year 3 is over and year 4 begins so all the counters re-set.
I'll be able to tweak the vertical axis next week so £0 to £1,000 is hidden.
Still a mountain to remove, but a few weeks later than with the other accounts.
Here's my virtual portfolio
Looking much better. I've climbed 686 places to 838th and am impressively in profit.
I don't think I'll sell anything as I think they all have further to go, and I'm not aware of any bargains to be had as I've not had time to do any research, so will leave it alone for now.
31st July will be an important date, as CEY:Centamin are releasing their outlook for 2020 and 2021. This is likely to cause a major re-rate, but I don't know in which direction. The SIPP is currently £484 (16%) up, whereas the ISA is £119 (8%) down. If the price goes up enough for the ISA to be back in profit, the SIPP will be £828 (27%) in profit and worth £3,842. The problem is, gold appears to be on a bull run, so although I could get my performance back up to 10%, do I really want to lose most of my gold holding now? I think not! I really need to stay focused on keeping profitable shares for the long term, particularly in the SIPP which I want to be the more stable account.
No comments:
Post a Comment